MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
Abstract Background Clinically hypomyopathic dermatomyositis is a rare disease that is important to recognize, investigate and treat early as it is associated with poor prognosis. In a proportion of patients, myositis specific antibodies could be negative, but with high clinical suspicion, myositis...
Main Authors: | Safi Alqatari, Peter Riddell, Sinead Harney, Michael Henry, Grainne Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-018-0622-8 |
Similar Items
-
Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
by: Zi Ying Li, et al.
Published: (2020-08-01) -
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yulu Qiu, et al.
Published: (2024-01-01) -
A Review of MDA-5 Dermatomyositis and Associated Interstitial Lung Disease
by: Sambhawana Bhandari, et al.
Published: (2024-02-01) -
Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment
by: Baptiste Hervier, et al.
Published: (2020-01-01) -
Coexistence of anti‐MDA5 and anti‐PL‐7 in a patient with dermatomyositis: A case report
by: Hongyan Fu, et al.
Published: (2023-01-01)